Margarida Gratacòs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Margarida Gratacòs has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Nuria Raguer
Department of Neurophysiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain
8 shared publications - Jose Luis Seoane
Department of Clinical Neurophysiology. Vall d'Hebron University Hospital. Passeig de la Vall d'Hebron, 119 Barcelona, Spain
5 shared publications - Josep Gamez
Hospital Universitari General de Catalunya, Barcelona, Spain
4 shared publications - Alfons Macaya
Department of Pediatric Neurology University Hospital Vall d'Hebron (HUVH), Vall d'Hebron University Hospital Research Institute (IIS IR‐HUVH) Barcelona Spain
3 shared publications - Elena Lainez
Department of Clinical Neurophysiology. Vall d'Hebron University Hospital. Passeig de la Vall d'Hebron, 119 Barcelona, Spain
3 shared publications - Arnau Llauradó
Neuromuscular Disorders Unit, Department of Neurology Vall D'hebron University Hospital Barcelona Spain
2 shared publications
Latest Publications
- 26 August 2025
- Published by Elsevier in Clinical Neurophysiology
- Vol. 179, 2110989
Electrophysiological findings in immune checkpoint inhibitor-related neuromuscular events
- 26 August 2025
- Published by Elsevier in Clinical Neurophysiology
- Vol. 179, 2110989
Electrophysiological findings in immune checkpoint inhibitor-related neuromuscular events
- Open Access
- 16 May 2023
- Published by Elsevier in Clinical Neurophysiology
- Vol. 150, e151
N°249 – Electrophysiological findings in immune checkpoint inhibitor – Associated neurologic toxicity
- 16 May 2023
- Published by Elsevier in Clinical Neurophysiology
- Vol. 150, e151
Open AccessN°249 – Electrophysiological findings in immune checkpoint inhibitor – Associated neurologic toxicity
- Open Access
- 1 September 2022
- Published by Elsevier in Clinical Neurophysiology
- Vol. 141, S124
TH-146. Neuromuscular involvement in severe Covid-19 patients. Our experience in EMG unit of terciary hospital
- 1 September 2022
- Published by Elsevier in Clinical Neurophysiology
- Vol. 141, S124
Open AccessTH-146. Neuromuscular involvement in severe Covid-19 patients. Our experience in EMG unit of terciary hospital
- 1 October 2019
- Published by Elsevier in Neuromuscular Disorders
- Vol. 29, S200
EP.110Clinical and neurophysiological outcome of a patient with predicted type 1 SMA presymptomatically treated with nusinersen
- 1 October 2019
- Published by Elsevier in Neuromuscular Disorders
- Vol. 29, S200
EP.110Clinical and neurophysiological outcome of a patient with predicted type 1 SMA presymptomatically treated with nusinersen
- 23 September 2015
- Published by Wiley in Muscle & Nerve
- Vol. 53 (1) , 156-157
Incomplete penetrance in the Spanish family with limb‐girdle muscular dystrophy type 1F
- 23 September 2015
- Published by Wiley in Muscle & Nerve
- Vol. 53 (1) , 156-157
Incomplete penetrance in the Spanish family with limb‐girdle muscular dystrophy type 1F
- 1 June 2014
- Published by Elsevier in Clinical Neurophysiology
- Vol. 125, S198
P548: SMA I. Review of sensory involvement in neurophysiological studies in our cohort
- 1 June 2014
- Published by Elsevier in Clinical Neurophysiology
- Vol. 125, S198
P548: SMA I. Review of sensory involvement in neurophysiological studies in our cohort
- 19 January 2013
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 41 (4) , 445-453
Brainstem dysgenesis during the neonatal period: diagnosis and management
Aims: To report our neonatal management experience in patients who received a diagnosis of brainstem dysgenesis (BSD). Patients and methods: This study retrospectively reviewed the medical records of 15 neonates with BSD diagnosed between 1984 and 2011. Data on the perinatal period, physical examination, laboratory findings, and management by systems were systematically analyzed. Results: All cases were sporadic. Cocaine abuse and misoprostol use were recorded in two pregnancies. The reason for admission was prematurity (2 of 15), respiratory distress (8 of 15), gastroschisis (1 of 15), and abnormal neurological examination (4 of 15). Clinically, the most commonly affected cranial nerves were the 7th (13 of 15), 9th (11 of 15), 10th (8 of 15), 5th (7 of 15), 12th (7 of 15), 6th (3 of 15), 4th (1 of 15), and 3rd (1 of 15). Five patients required positive pressure ventilation during delivery room resuscitation, three had difficult airways, and two needed tracheostomy during admission. Most patients required nasogastric tube feeding shortly after birth, and four patients had a gastrostomy on discharge. Two patients died of respiratory and cardiac failure. Electromyography and nerve conduction velocity were used to exclude generalized neuromuscular disorders, and in conjunction with other neurophysiological and gastrointestinal tract studies, helped uncover the extent of brainstem involvement in most cases. Cranial magnetic resonance imaging supported the diagnosis in more than half of the patients. Conclusions: Early diagnosis of BSD is mainly clinical, difficult to establish unless suspected, and crucial to prevent complications. Neonatal care of patients with BSD requires a comprehensive approach that must take into consideration the etiological, anatomical, and pathogenic aspects contributing to the clinical manifestations of this disorder. Care should be provided by multidisciplinary teams, in which neonatologists, pediatric neurologists, nutritionists, physical therapists, and other professionals participate, depending on the associated morbidity in order to improve its management and prognosis.
- 19 January 2013
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 41 (4) , 445-453
Brainstem dysgenesis during the neonatal period: diagnosis and management
Aims: To report our neonatal management experience in patients who received a diagnosis of brainstem dysgenesis (BSD). Patients and methods: This study retrospectively reviewed the medical records of 15 neonates with BSD diagnosed between 1984 and 2011. Data on the perinatal period, physical examination, laboratory findings, and management by systems were systematically analyzed. Results: All cases were sporadic. Cocaine abuse and misoprostol use were recorded in two pregnancies. The reason for admission was prematurity (2 of 15), respiratory distress (8 of 15), gastroschisis (1 of 15), and abnormal neurological examination (4 of 15). Clinically, the most commonly affected cranial nerves were the 7th (13 of 15), 9th (11 of 15), 10th (8 of 15), 5th (7 of 15), 12th (7 of 15), 6th (3 of 15), 4th (1 of 15), and 3rd (1 of 15). Five patients required positive pressure ventilation during delivery room resuscitation, three had difficult airways, and two needed tracheostomy during admission. Most patients required nasogastric tube feeding shortly after birth, and four patients had a gastrostomy on discharge. Two patients died of respiratory and cardiac failure. Electromyography and nerve conduction velocity were used to exclude generalized neuromuscular disorders, and in conjunction with other neurophysiological and gastrointestinal tract studies, helped uncover the extent of brainstem involvement in most cases. Cranial magnetic resonance imaging supported the diagnosis in more than half of the patients. Conclusions: Early diagnosis of BSD is mainly clinical, difficult to establish unless suspected, and crucial to prevent complications. Neonatal care of patients with BSD requires a comprehensive approach that must take into consideration the etiological, anatomical, and pathogenic aspects contributing to the clinical manifestations of this disorder. Care should be provided by multidisciplinary teams, in which neonatologists, pediatric neurologists, nutritionists, physical therapists, and other professionals participate, depending on the associated morbidity in order to improve its management and prognosis.
- 1 September 2010
- Published by Elsevier in Cytotherapy
- Vol. 12 (5) , 669-677
Cellular transplants in amyotrophic lateral sclerosis patients: an observational study
- 1 September 2010
- Published by Elsevier in Cytotherapy
- Vol. 12 (5) , 669-677
Cellular transplants in amyotrophic lateral sclerosis patients: an observational study
- 1 August 2010
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 295 (1-2) , 110-113
Paroxysmal exercise-induced dyskinesia, writer's cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation
- 1 August 2010
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 295 (1-2) , 110-113
Paroxysmal exercise-induced dyskinesia, writer's cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation
- 15 July 2010
- Published by Wiley in Movement Disorders
- Vol. 25 (9) , 1293-1295
Camptocormia associated with an expanded allele in the TATA box‐binding protein gene
- 15 July 2010
- Published by Wiley in Movement Disorders
- Vol. 25 (9) , 1293-1295
Camptocormia associated with an expanded allele in the TATA box‐binding protein gene